First head-to-head study in people living with obesity shows tirzepatide results in around 50% more weight loss than semaglutide
A new head-to-head study of tirzepatide versus semaglutide for weight loss in people living with obesity, but not diabetes, shows that over 72 weeks tirzepatide results in an […]
